mhurhangee/ep-ind-claims huggingface dataset:
A dental implant system, comprising - a dental implant (1; 100; 30; 40; 50; 70), having an implant frustoconical cavity (2; 200; 31; 41; 51; 71) with a dental implant apical end and an abutment inlet end, - an abutment having an abutment post of size and shape such as to be permanently retained in the implant frustoconical cavity (2; 200; 31; 41; 51; 71) of the dental implant (1; 100; 30; 40; 50; 70) and an abutment head suitable for supporting a dental crown, - a dental transfer (4; 400) having a transfer post (5; 500) intended to be inserted into the implant frustoconical cavity (2; 200; 31; 41; 51; 71) of the dental implant (1; 100; 30; 40; 50; 70) before an impression taking, and a transfer head identical to the abutment head of the abutment, and - an implant analog having an analog internal cavity suitable for receiving the transfer post (5; 500) of the dental transfer (4; 400), and an outer surface provided with undercuts so that the implant analog is retained inside a plaster model in casting a dental model into said impression, the dental implant system being characterized in that the dental implant apical end is hollow and communicates with outside of the dental implant (1; 100; 30; 40; 50; 70) and in that the implant frustoconical cavity (2; 200; 31; 41; 51; 71) of the dental implant (1; 100; 30; 40; 50; 70) is a through hole, such that the dental implant is open from the dental implant apical end to the abutment inlet end. - a dental implant (1; 100; 30; 40; 50; 70), having an implant frustoconical cavity (2; 200; 31; 41; 51; 71) with a dental implant apical end and an abutment inlet end, - an abutment having an abutment post of size and shape such as to be permanently retained in the implant frustoconical cavity (2; 200; 31; 41; 51; 71) of the dental implant (1; 100; 30; 40; 50; 70) and an abutment head suitable for supporting a dental crown, - a dental transfer (4; 400) having a transfer post (5; 500) intended to be inserted into the implant frustoconical cavity (2; 200; 31; 41; 51; 71) of the dental implant (1; 100; 30; 40; 50; 70) before an impression taking, and a transfer head identical to the abutment head of the abutment, and - an implant analog having an analog internal cavity suitable for receiving the transfer post (5; 500) of the dental transfer (4; 400), and an outer surface provided with undercuts so that the implant analog is retained inside a plaster model in casting a dental model into said impression, the dental implant system being characterized in that the dental implant apical end is hollow and communicates with outside of the dental implant (1; 100; 30; 40; 50; 70) and in that the implant frustoconical cavity (2; 200; 31; 41; 51; 71) of the dental implant (1; 100; 30; 40; 50; 70) is a through hole, such that the dental implant is open from the dental implant apical end to the abutment inlet end.
Method for producing a rotationally symmetrical, in particular a cylindrical, screen device, having a multiplicity of profiled rods, in which method first strip-type rod holders are generated, the shape of the latter deviating from the later annular shape in the finished screen device, and said first rod holders being provided with peripherally open clearances into which the profiled rods are insertable; the profiled rods are inserted in a mutually parallel manner into the peripherally open clearances of the first rod holders; rings are generated from the first rod holders that are provided with the profiled rods by bending; the profiled rods by way of this bending, on account of the constricting clearances, are jammed in these clearances; and the first rod holders after bending are fixedly interconnected at the two abutting ends thereof, characterized in that additionally to the first strip-type rod holders, in each case at least one further strip-type rod holder having peripherally open clearances is generated, the shape of said rod holder deviating from the later annular shape in the finished screen device, and the height (h 16) thereof, measured in the radial direction of the later annular shape, being less than the height (h 14) of the respective first rod holder; rod holder packs from in each case one first strip-type rod holder and at least one further strip-type rod holder that in the axial direction of the finished screen device is provided so as to be directly adjacent to or at a certain spacing from said first rod holder are formed from the first strip-type rod holders and the further strip-type rod holders that are assigned to said first rod holders; the profiled rods are inserted in a mutually parallel manner into the peripherally open clearances of the rod holder packs; the further rod holders are conjointly bent by way of bending the first rod holders and, on account thereof, the profiled rods on account of the constricting clearances of the further rod holders are also jammed in the clearances of these further rod holders; and the rod holder packs after bending are fixedly interconnected at the two abutting ends thereof.
A plasma control apparatus for supplying radio-frequency power to a plasma processing apparatus, the plasma processing apparatus comprising a coil for generating inductively coupled plasma or an electrode for generating capacitively coupled plasma, and a stage on which a substrate is placed, the placed substrate being subjected to processing using any one of the inductively coupled plasma and the capacitively coupled plasma, wherein the plasma control apparatus comprises: a power source unit configured to supply radio-frequency power to the stage; a resonance producing unit: interposed between the power source unit and the stage, and configured to apply the radio-frequency power supplied from the power source unit to the stage; and a voltmeter configured to measure a voltage of the stage, the resonance producing unit comprises: an LC circuit formed by a coil and a capacitor connected to each other; and characterised in that the resonance producing unit further comprises a sensor configured to detect a phase difference between current flowing in and voltage applied to the LC circuit, a capacitance of the capacitor of the LC circuit is larger than an expected capacitance of the plasma, and the power source unit is configured to control a magnitude of the radio-frequency power to be supplied in such a manner as to bring the voltage measured with the voltmeter close to a set voltage as a target, and is configured to control a frequency of the radio-frequency power to be supplied in such a manner as to minimize the phase difference detected with the sensor. a power source unit configured to supply radio-frequency power to the stage; a resonance producing unit: interposed between the power source unit and the stage, and configured to apply the radio-frequency power supplied from the power source unit to the stage; and a voltmeter configured to measure a voltage of the stage, an LC circuit formed by a coil and a capacitor connected to each other; and characterised in that the resonance producing unit further comprises a sensor configured to detect a phase difference between current flowing in and voltage applied to the LC circuit, a capacitance of the capacitor of the LC circuit is larger than an expected capacitance of the plasma, and the power source unit is configured to control a magnitude of the radio-frequency power to be supplied in such a manner as to bring the voltage measured with the voltmeter close to a set voltage as a target, and is configured to control a frequency of the radio-frequency power to be supplied in such a manner as to minimize the phase difference detected with the sensor.
A heat-shrinking apparatus for shrink labels comprising; a heating treatment chamber surrounding a conveyance path of a label covered body in which a part of or the whole of an article is covered by a shrink label; a steam supply device that heat-shrinks the shrink label on the label covered body passing through the heating treatment chamber by supplying superheated steam into the heating treatment chamber; the apparatus being characterized in that it comprises: a heated air generating device that generates heated air at a predetermined temperature; and a heated air blowing device that evaporates water drops by blowing the heated air being generated by the heated air generating device to the label covered body on which the water drops are deposited due to passage through the heating treatment chamber to which the superheated steam is supplied; and in that the heated air generating device includes: a preheating device that preheats the air by using surplus steam in the heating treatment chamber; and a heating device that heats the air preheated by the preheating device to a predetermined temperature. a heated air generating device that generates heated air at a predetermined temperature; and a heated air blowing device that evaporates water drops by blowing the heated air being generated by the heated air generating device to the label covered body on which the water drops are deposited due to passage through the heating treatment chamber to which the superheated steam is supplied; and in that the heated air generating device includes: a preheating device that preheats the air by using surplus steam in the heating treatment chamber; and a heating device that heats the air preheated by the preheating device to a predetermined temperature. a preheating device that preheats the air by using surplus steam in the heating treatment chamber; and a heating device that heats the air preheated by the preheating device to a predetermined temperature.
A reaction mixture for determining the presence or absence of Epstein-Barr virus in a sample, said reaction mixture comprising: a detection probe oligomer for detecting EBV nucleic acids, wherein the detection probe oligomer is up to 30 nucleotides in length and comprises the base sequence of SEQ ID NO:22 or the complement thereof, allowing for substitution of RNA and DNA equivalent bases; and a pair of amplification oligomers, wherein a first amplification oligomer of the pair comprises 18-25 contiguous bases of SEQ ID NO:3, allowing for substitution of RNA and DNA equivalent bases, and wherein a second amplification oligomer of the pair comprises 18-25 contiguous bases of SEQ ID NO:4, allowing for substitution of RNA and DNA equivalent bases. a detection probe oligomer for detecting EBV nucleic acids, wherein the detection probe oligomer is up to 30 nucleotides in length and comprises the base sequence of SEQ ID NO:22 or the complement thereof, allowing for substitution of RNA and DNA equivalent bases; and a pair of amplification oligomers, wherein a first amplification oligomer of the pair comprises 18-25 contiguous bases of SEQ ID NO:3, allowing for substitution of RNA and DNA equivalent bases, and wherein a second amplification oligomer of the pair comprises 18-25 contiguous bases of SEQ ID NO:4, allowing for substitution of RNA and DNA equivalent bases. wherein a first amplification oligomer of the pair comprises 18-25 contiguous bases of SEQ ID NO:3, allowing for substitution of RNA and DNA equivalent bases, and wherein a second amplification oligomer of the pair comprises 18-25 contiguous bases of SEQ ID NO:4, allowing for substitution of RNA and DNA equivalent bases.
Method for processing organic cells, wherein the method comprises the following steps: providing a microfluidic system having a chamber comprising a stationary phase in the form of a plurality of microparticles; letting a plurality of organic cells in a mobile phase into the chamber across a first opening of the microfluidic system; accumulating the organic cells in a section of the chamber in which the microparticles are deposited and that is upstream of a filter of the microfluidic system that is impermeable to the microparticles; and characterized by flushing a lysis agent into the chamber via a channel which opens into the section of the chamber in order to resuspend the microparticles and the organic cells in the chamber for a disruption of the organic cells. providing a microfluidic system having a chamber comprising a stationary phase in the form of a plurality of microparticles; letting a plurality of organic cells in a mobile phase into the chamber across a first opening of the microfluidic system; accumulating the organic cells in a section of the chamber in which the microparticles are deposited and that is upstream of a filter of the microfluidic system that is impermeable to the microparticles; and characterized by flushing a lysis agent into the chamber via a channel which opens into the section of the chamber in order to resuspend the microparticles and the organic cells in the chamber for a disruption of the organic cells.
A multilayer structure each layer of which having opposing facial surfaces, the structure comprising a top layer comprising a maleic anhydride modified (MAH-m) polyolefin (MAH-m-polyolefin) or a blend of a polyolefin and a MAH-m-polyolefin and having a top facial surface and a bottom facial surface, a first tie layer comprising a copolymer of an ethylene with a glycidyl ester of an unsaturated carboxylic acid and an optional third monomer, the tie layer having a top facial surface and a bottom facial surface, the top facial surface in adhering contact with the bottom facial surface of the top layer, and a bottom layer comprising a blend of a propylene polymer and a MAH-m-polyolefin, the blend having at least one melting peak on a Differential Scanning Calorimetry curve of greater than 140 °C and having a top facial surface and a bottom facial surface, the top facial surface in adhering contact with the bottom facial surface of the first tie layer.
A method of producing purified human papillomavirus virus-like particles (VLPs), comprising: (i) purifying a disassembled recombinantly expressed HPV L1 protein capable of forming a VLP in the presence of at least one sulfhydryl reducing agent that maintains said recombinantly expressed HPV L1 protein in a disassembled form; and (ii) assembling said recombinantly expressed HPV L1 protein into purified human papillomavirus virus-like particles (VLPs) by removing or oxidising said at least one reducing agent. (i) purifying a disassembled recombinantly expressed HPV L1 protein capable of forming a VLP in the presence of at least one sulfhydryl reducing agent that maintains said recombinantly expressed HPV L1 protein in a disassembled form; and (ii) assembling said recombinantly expressed HPV L1 protein into purified human papillomavirus virus-like particles (VLPs) by removing or oxidising said at least one reducing agent.
A method of prognosis of a subject with a cancer and/or identifying a subject having a greater risk of having an undiagnosed cancer the method comprising detecting an amount of free light chains in a sample of whole blood, plasma or serum from a subject, wherein a higher amount of FLC is associated with decreased survival due to a cancer and/or increased risk of the subject having an undiagnosed cancer wherein the cancer is a lung, colorectal, small bowel, oesophageal or pancreatic (LCBOP) cancer which is not a B-cell associated disease or a myeloma (such as intact immunoglobulin myeloma, light chain myeloma, non-secretory myeloma), an MGUS, AL amyloidosis, Waldenström's macro globulinaemia, Hodgkin's lymphoma, follicular centre cell lymphoma, chroniclymphocytic leukaemia, mantle cell lymphoma, pre-B cell leukaemia or acute lymphoblastic leukaemia, and wherein the amount of free light chains is the amount of total free light chains in the sample.
A catalytically active variant of arylalkylamine N-acetyltransferase (AANAT) from Streptomyces griseofuscus (SEQ ID NO:1), the variant AANAT having at least 85% sequence identity to SEQ ID NO:1, comprising a mutation in residue D63 and providing for an increased yield in vivo of N-acetylserotonin from serotonin relative to native enzyme having the amino acid sequence of SEQ ID NO:1, wherein the mutation in residue D63 is an amino acid substitution selected from D63G, D63A, D63V, D63L and D63I.
An insulation resistance measuring circuit for measuring an insulation resistance between a chassis ground of a vehicle and a high voltage battery, characterized by comprising: a source resistor unit including a first source resistor connected between a positive terminal of the battery and ground and the second source resistor connected between a negative terminal of the battery and ground a voltage sensing unit sensing a voltage of the first source resistor as a first voltage and sensing a voltage of the second source resistor as a second voltage; and an insulation resistance measuring unit measuring an insulation resistance of the battery through a value obtained by dividing a difference between the first and second voltages by a sum between the first and second voltages. a source resistor unit including a first source resistor connected between a positive terminal of the battery and ground and the second source resistor connected between a negative terminal of the battery and ground a voltage sensing unit sensing a voltage of the first source resistor as a first voltage and sensing a voltage of the second source resistor as a second voltage; and an insulation resistance measuring unit measuring an insulation resistance of the battery through a value obtained by dividing a difference between the first and second voltages by a sum between the first and second voltages.
Multi-functional toilet assembly with an actuating device, a flushing device comprising a concealed cistern and being actuable by means of the actuating device, a toilet body (2, 56, 62, 72, 74) with a flushing rim, a flushing water inlet connectable to the flushing device, a waste water outlet, a wall, a cover wall and at least one further functional element, wherein, in addition to the flushing device, technical elements required for the operation of the at least one functional element are arranged in the wall behind the toilet body and an opening in the wall behind the toilet body (2, 56, 62, 72, 74) is provided, which can be closed via the cover wall (18, 48, 50, 54, 60, 70) which can be detachably fastened in front of the wall, CHARACTERIZED IN THAT the opening is designed as an inspection opening, via which easy access for maintenance and retrofitting of the technical elements required for the operation of the at least one further functional element is enabled and which extends at least from the upper edge of the toilet body (2, 56, 62, 72, 74) to the actuating device integrated in the cover wall.
A T cell receptor which has an artificial interchain disulfide bond formed by introducing a cysteine residue into TCR α chain and β chain constant region, wherein the TCR having an artificial interchain disulfide bond has a Tm ≥45°C; wherein the cysteine residues that form an artificial interchain disulfide bond are at a substitution position selected from: (a) R53C Exon 1 of TRAC*01, and S54C in Exon 1 of TRBC1*01 or TRBC2*01; or (b) Y10C in Exon 1 of TRAC*01, and E20C in Exon 1 of TRBC1*01 or TRBC2*01. (a) R53C Exon 1 of TRAC*01, and S54C in Exon 1 of TRBC1*01 or TRBC2*01; or (b) Y10C in Exon 1 of TRAC*01, and E20C in Exon 1 of TRBC1*01 or TRBC2*01.
An explosion suppression system, comprising: a cannon comprising a barrel and a propellant tank, the propellant tank containing a propellant; a suppressant cartridge configured to be inserted into the barrel, the suppressant cartridge containing a suppressant, and comprising an outlet seal; and, a triggering mechanism (1040, 1041) positioned between the barrel and propellant tank, the triggering mechanism configured to release propellant from the propellant tank into the barrel and suppressant cartridge when the triggering mechanism is triggered, thereby propelling suppressant from an outlet of the cannon; and a seal actuator configured to weaken or burst the outlet seal when propellant is released from the propellant tank; characterized in that the seal actuator is a first seal actuator, the system further comprising a second seal actuator configured to weaken or burst the outlet seal when propellant is released from the propellant tank. a cannon comprising a barrel and a propellant tank, the propellant tank containing a propellant; a suppressant cartridge configured to be inserted into the barrel, the suppressant cartridge containing a suppressant, and comprising an outlet seal; and, a triggering mechanism (1040, 1041) positioned between the barrel and propellant tank, the triggering mechanism configured to release propellant from the propellant tank into the barrel and suppressant cartridge when the triggering mechanism is triggered, thereby propelling suppressant from an outlet of the cannon; and a seal actuator configured to weaken or burst the outlet seal when propellant is released from the propellant tank; characterized in that the seal actuator is a first seal actuator, the system further comprising a second seal actuator configured to weaken or burst the outlet seal when propellant is released from the propellant tank.
A cell differentiation state evaluation method, wherein stem cells for which a differentiation state is unknown or cells differentiation-induced from pluripotent stem cells are used as test cells, and pluripotent stem cells are used as control cells, and a differentiation state of the test cells is evaluated by comparing abundances of indicator substances in a culture supernatant of the test cells with abundances of the indicator substances in a culture supernatant of the control cells, characterizing in that the indicator substances are two or more kinds of compounds selected from a group consisting of ornithine, 2-aminoadipic acid, deoxycytidine, tryptophan, hypoxanthine, uridine and kynurenine. stem cells for which a differentiation state is unknown or cells differentiation-induced from pluripotent stem cells are used as test cells, and pluripotent stem cells are used as control cells, and a differentiation state of the test cells is evaluated by comparing abundances of indicator substances in a culture supernatant of the test cells with abundances of the indicator substances in a culture supernatant of the control cells, characterizing in that the indicator substances are two or more kinds of compounds selected from a group consisting of ornithine, 2-aminoadipic acid, deoxycytidine, tryptophan, hypoxanthine, uridine and kynurenine.